Microarray analysis of genes from animals treated with a traditional formulation ChandraprabhaVati reveals its therapeutic targets

10.1016/j.jtcme.2019.08.001

Pratheppa Rajagopal；David Raj Chellappan；Sriram Sridharan；Brindha Pemiah；Sridharan Krishnaswamy；Swaminathan Sethuraman；KalpoondiRajan Sekar；Uma Maheswari Krishnan

ChandraprabhaVati ； Ayurveda ； Microarray analysis

Journal of Traditional and Complementary Medicine

10卷1期（2020 / 01 / 01）

36 - 44

英文

Background: Traditional medicinal preparations have not received global acceptance, and their therapeutic benefits remain disputed due to lack of scientific evidence on their mechanism of action. Microarray analysis has emerged as a powerful technique that can aid in understanding the complex signaling networks activated by these formulations and thereby assess their beneficial as well as adverse effects. Aim: The present work aims to investigate the differential influence of ChandraprabhaVati, Ayurvedic formulation used in the treatment of diabetes, anemia, urinary, respiratory, skin and liver disorders. Materials and methods: The RNA from the liver of rats treated with different doses of ChandraprabhaVati for 28 days was isolated and studied for the genome-wide changes in the expression. Results: The results revealed several molecular targets that could contribute to the therapeutic effects of ChandraprabhaVati. Several genes have been differentially expressed, among those miRNAs miR-434, miR877, and miRlet7e contribute to the anti-diabetic, anti-fibrotic and anti-inflammatory of CPV. The rejuvenative activity of CPV may be due to the MeOX1 and Upf3b genes. Up-regulation of Hbaa2 gene facilitates the anti-anemic effect. Interestingly gender-specific differential expressions of genes were also observed. Rab3d were found to be altered in female when compared to male animals. Conclusion: Thus the microarray data for the CPV treated animals has revealed molecular targets that may be responsible for the various known therapeutic effects and also identified new beneficial effects of CPV.

1. Abaffy, T(2015).Human olfactory receptors expression and their role in non-olfactory tissues â€Â" a mini-review.J Pharmacogenomics Pharmacoproteomics,06(04)
2. Bagul, MS,Kanaki, NS,Rajani, M(2005).Evaluation of free radical scavenging properties of two classical polyherbal formulations.Indian J Exp Biol,43(8),732-736.
3. Brewer, CT(2017).Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.Int. J. Mol. Sci.,18(1),2353.
4. Chavan, P,Joshi, K,Patwardhan, B(2006).DNA microarrays in herbal drug research.Evid Based Complement Altern Med,3(4),447-457.
5. Choi, RCY,Gao, QT,Cheung, AWH(2011).A Chinese herbal decoction, danggui buxue Tang, stimulates proliferation, differentiation and gene expression of cultured osteosarcoma cells: genomic approach to reveal specific gene activation.Evidence-Based Complement Altern Med,2011,1-13.
6. Christa, SS,Swetha, A,Christina, E,Ganesh, RN,Viswanathan, P(2013).Modulatory effect of chandraprabha vati on antimicrobial peptides and inflammatory markers in kidneys of mice with urinary tract infection.Iran J Kidney Dis.,7(5),390-398.
7. Delic, D,Eisele, C,Schmid, R,Luippold, G,Mayoux, E,Grempler, R(2016).Characterization of micro-RNA changes during the progression of type 2 diabetes in Zucker diabetic fatty rats.Int J Mol Sci.,17(5),1-16.
8. Douville, JM,Cheung, DYC,Herbert, KL,Moffatt, T,Wigle, JT(2011).Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21CIP1/WAF1 and p16INK4a in vascular endothelial cells.PLoS One,6(12),e29099.
9. Dumbre, RK(2012).Effect of Chandraprabha Vati in Experimental Prostatic Hyperplasia and Inflammation in Rats.Journal of Pharmacy Research,5(12),5302-5304.
10. Ferrer, I,Garcia-Esparcia, P,Carmona, M(2016).Olfactory receptors in non- chemosensory organs: the nervous system in health and disease.Front Aging Neurosci,8
11. Jamadagni, PS,Jamadagni, SB,Singh, A(2015).Toxicity study of swarna bhasma, an ayurvedic medicine containing gold, in wistar rats.Toxicol Int (Formerly Indian J Toxicol.,22(3),11.
12. Kagawa, T,Watanabe, M,Inoue, N(2016).Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.Endocr J.,63(4),375-380.
13. Kiyama, R(2017).DNA microarray-based screening and characterization of traditional Chinese medicine.Microarrays,6(1),4.
14. Klein, A,Wrulich, OA,Jenny, M(2013).Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies.BMC Genomics,14(1),1-14.
15. Kuver, R(2012).Mechanism of oxystero-induced disease: insights from the biliary system.Clin Lipidol,7(5),537-548.
16. Kwekel, JC,Vijay, V,Han, T,Moland, CL,Desai, VG,Fuscoe, JC(2017).Sex and age differences in the expression of liver microRNAs during the life span of F344 rats.Biol Sex Differ,8(1),1-21.
17. Li, C-C,Lo, H-Y,Hsiang, C-Y,Ho, T-Y(2012).DNA microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of Chinese medicinal herbs.Biomedicine,2(1),10-16.
18. Marianne, J.(2010).BT - Principles of Genderspecific Medicine.San Diego:Academic Press.
19. Martin, E,Palmic, N,Sanquer, S(2014).CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation.Nature,510(7504),288-292.
20. Millar, AL,Pavlos, NJ,Xu, J,Zheng, MH(2002).Rab3D: a regulator of exocytosis in nonneuronal cells.Histol Histopathol,17(3),929-936.
21. Ministry for Health and Family Welfare(2010).The ayurvedic pharmacopoeia of India.The Ayurvedic Pharmacopoeia of India,2,171.
22. Mölleken, C,Sitek, B,Henkel, C(2009).Detection of novel biomarkers of liver cirrhosis by proteomic analysis.Hepatology,49(4),1257-1266.
23. Murakami, Y,Toyoda, H,Tanaka, M(2011).The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.PLoS One,6(1)
24. Olivera, A,Kitamura, Y,Wright, LD(2013).Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression.J Leukoc Biol,94(5),1013-1024.
25. Raghu, KS,Shamprasad, BR,Kabekkodu, SP(2017).Age dependent neuroprotective effects of medhya rasayana prepared from Clitoria ternatea Linn. in stress induced rat brain.J Ethnopharmacol,197,173-183.
26. Rajani, M,Bagul, M,Srinivasa, H,Kanaki, N(2005).Antiinflammatory activity of two Ayurvedic formulations containing guggul.Indian J Pharmacol,37(6),399.
27. Reagan-Shaw, S,Nihal, M,Ahmad, N(2007).Dose translation from animal to human studies revisited.FASEB J.,22(3),659-661.
28. Selvaraj, S,Ramanathan, R,Vasudevaraja, V(2014).Transcriptional Regulation of the Pregnane-X Receptor by the Ayurvedic Formulation Chandraprabha Vati.RSC Advances,110
29. Shang, FF,Xia, QJ,Liu, W(2016).MiR-434-3p and DNA hypomethylation coregulate eIF5A1 to increase AChRs and to improve plasticity in SCT rat skeletal muscle.Sci Rep,6
30. Shum, EY,Jones, SH,Shao, A(2016).The antagonistic gene paralogs Upf3a and Upf3b govern nonsense-mediated RNA decay.Cell,165(2),382-395.
31. Smith, MA,Maurin, M,Cho, H, Il(2010).PRDM1/Blimp-1 controls effector cytokine production in human NK cells.J Immunol,185(10)
32. Tarkang, PA,Appiah-Opong, R,Ofori, MF,Ayong, LS,Nyarko, AK(2016).Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification.Biomark Res,4(1),25.
33. Tripathi, AK,Pandey, SD,Sastry, JLN,Vedula, S(2016).Observations on clinical safety of chandraprabha.Vati- An Ayurvedic Metallo-Herbo Mineral Formulation,1,17-23.
34. Wang, C,Gu, S,Cao, H(2016).MiR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis.Sci Rep,6
35. Wang, K,Holterman, AX(2012).Pathophysiologic role of hepatocyte nuclear factor 6.Cell Signal,24(1),9-16.
36. Wang, Z,Du, Q,Wang, F(2004).Microarray Analysis of Gene Expression on Herbal Glycoside Recipes Improving Deficient Ability of Spatial Learning Memory in Ischemic Mice.J. Neurochem.,88(6),1406-1415.
37. Wanjari, MM,Mishra, S,Dey, YN,Sharma, D,Gaidhani, SN,Jadhav, AD(2016).Antidiabetic activity of Chandraprabha vati - a classical Ayurvedic formulation.J Ayurveda Integr Med.,7(3),144-150.
38. Waring, JF,Gum, R,Morfitt, D(2002).Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor.Toxicology,181-182,537-550.
39. Wen, Z,Wang, Z,Wang, S(2011).Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression Microarray and Connectivity Map.PLoS One,6(3)
40. Yang, J,Liu, W,Lu, X,Fu, Y,Li, L,Luo, Y(2015).High expression of small GTPase Rab3D promotes cancer progression and metastasis.Oncotarget,6(13)
41. Yu, H,Königshoff, M,Jayachandran, A(2008).Transgelin is a direct target of TGF-β/Smad3-dependent epithelial cell migration in lung fibrosis.FASEB J.,22(6),1778-1789.